Stem Cell Therapy for Lungs
肺病干细胞治疗
Duration
5-10 days per treatment cycle
Recovery
Minimal downtime; lung function improvements over 3-6 months
Savings
~70% vs US
Average savings compared to US prices
Mesenchymal stem cell therapy targeting chronic lung diseases including COPD, pulmonary fibrosis, and post-COVID lung damage. Chinese research institutions have conducted multiple clinical trials demonstrating the anti-inflammatory and regenerative potential of MSCs in lung tissue. Treatment involves IV infusion of stem cells that home to damaged lung tissue, reducing inflammation and potentially promoting tissue repair.
Pulmonary Assessment
Complete lung function testing (spirometry, DLCO), CT imaging, 6-minute walk test, and blood gas analysis to establish baseline
Duration: 1-2 daysCell Preparation
Screening and preparation of allogeneic umbilical cord MSCs or autologous bone marrow MSCs meeting release criteria
Duration: 1-2 daysIV Stem Cell Infusion
Controlled intravenous infusion of stem cells over 1-2 hours with vital sign monitoring; typically 2-3 infusions per cycle
Duration: 3-5 daysPulmonary Rehabilitation
Breathing exercises, chest physiotherapy, and oxygen optimization alongside follow-up lung function testing
Duration: 1-2 weeks- Anti-inflammatory properties of MSCs may slow disease progression
- Non-invasive IV delivery with minimal procedural risk
- Multiple Chinese clinical trials show promising safety data
- Combined with pulmonary rehab for comprehensive lung improvement
- Efficacy not yet proven in large randomized controlled trials
- Temporary fever or fatigue after cell infusion
- Does not reverse established structural lung damage
- Multiple treatment cycles may be needed for sustained benefit
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.